Compare HALO & VSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | VSAT |
|---|---|---|
| Founded | 1998 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 9.6B |
| IPO Year | 2001 | 1996 |
| Metric | HALO | VSAT |
|---|---|---|
| Price | $107.93 | $70.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 11 |
| Target Price | $99.56 | ★ $103.94 |
| AVG Volume (30 Days) | ★ 2.0M | 1.4M |
| Earning Date | 11-02-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.42 |
| EPS | ★ 3.11 | N/A |
| Revenue | ★ $151,862,000.00 | N/A |
| Revenue This Year | $32.72 | $4.53 |
| Revenue Next Year | $10.61 | $4.59 |
| P/E Ratio | $36.16 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.23 | $29.13 |
| 52 Week High | $116.85 | $93.03 |
| Indicator | HALO | VSAT |
|---|---|---|
| Relative Strength Index (RSI) | 54.81 | 40.44 |
| Support Level | $104.49 | $67.16 |
| Resistance Level | $111.15 | $77.90 |
| Average True Range (ATR) | 3.04 | 3.34 |
| MACD | -0.71 | -0.41 |
| Stochastic Oscillator | 42.53 | 6.12 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Viasat Inc an world-wide provider of communications technologies and services, focused on making connectivity accessible, available and secure for current and future customers world-wide. The company has two reportable segments: communication services and defense and advanced technologies. It generates majority of revenue from communication services segment provides a wide range of broadband and narrowband communications solutions across government and commercial mobility markets, as well as for residential and enterprise fixed broadband customers. It has presence in United States and Outside United States. The company generates majority of revenue from United States. Its products are Antennas, Terminals & radios, Modems, Semiconductors, Cybersecurity, Software & services, Home internet.